References
- Hawker C D, DiBella F P. Parathyrdid hormone in chronic renal failure: studies with two different parathyroid hormone radioimmunoassays. Cont Nephrol 1980; 20: 21–37
- Lilienfeld-Toal von H, Gerach I, Klehr H U, Issa S, Keck E. Immunoreactive parathyroid hormone in early and advanced renal failure. Nephron 1982; 31: 116–22
- Bogin E, Massry S G, Harary I. Effect of parathyroid hormone on rat heart cells. J Clin Invest 1981; 67: 1215–27
- Massry S G. The toxic effects of parathyroid hormone in uremia. Seminars in Nephrology 1983; 3: 306–28
- Yalow R S. Clinical significance of the heterogeneity of parathyroid hormone. Contr Nephrol 1980; 20: 15–20
- Myhre L. A convenient rat bioassay for calcitonin (CT) using measurements of ionized calcium (Ca++) in serum. Acta Physiol Scand 1980; 108: 41A–42A
- Gautvik K M, Gautvik V T, Halvorsen J F. Characterization of the molecular form of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure. Scand J Clin Lab Invest 1983; 43: 553–64
- Gautvik K M, Teig V, Halvorsen J F, Arnescn E, Myhre L, Heimann P, Tollman R. Development of sequence specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis of hyperparathyroidism. Scand J Clin Lab Invest 1979; 39: 469–78
- Gautvik K M, Normann T, Teig V, Wille SØ, Brennhovd I O, Christcnsen I. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland. Scand J Clin Lab Invest 1976; 36: 323–9
- Myhre E, Gautvik K M. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland. Acta Endocrinol 1979; 91: 449–61
- Adami S, Muirhead N, Manning R M, Gleed J H, Papapoulos S E, Sandler L M, Catto G RD, O'Riordan J LH. Control of secretion of parathyroid hormone in secondary hyperparathyroidism. Clin Endocrinol 1982; 16: 463–73
- Muirhead N, Catto G RD, Edward N, Adami S, Manning R M, O'Riordan J LH. Suppression of secondary hyperparathyroidism in uraemia: acute and chronic studies. Br Med J 1984; 288: 177–9
- Garancini S, Ballada L, Roncari G, Gastaldi L. Calcitonin in chronic renal failure. Nephron 1983; 34: 224–7
- Martinez M E, Miguel J L, Gomez P, Selgas R, Salinas M, Gentil M, Mateos F, Montero J L, Sanches Sicilia L. Plasma calcitonin concentrations in patients treated with chronic dialysis: differences between haemodialysis and CAPD. Clin Nephrol 1983; 19: 250–3
- Mulder H, Silberbusch J, Hackeng W HL, Koorevaar G, den Ottolander G JH. Enhanced calcitonin release in chronic renal failure depending on the absence of severe secondary hyperparathyroidism. Nephron 1982; 31: 123–8
- Gautvik K M, Gordeladze J O, Moxheim E, Gautvik V T. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies. Eur Surg Res 1984; 16: 41–54, suppl. 2